Monges Viviane sold $293K of PHVS
Monges Viviane sold 9,667 shares of Pharvaris N.V. (PHVS) at $30.29 ($0.29M total) on 2026-05-21.
How this was made
The 30-second read
Why it matters
The disclosure may modestly influence short-term sentiment, but it does not provide new information about Pharvaris’ pipeline, finances, or near-term catalysts.
Market read
Traders may monitor PHVS for follow-on insider activity, but this filing alone is unlikely to drive a sustained repricing.
What to watch
Check for other insiders’ transactions around the same dates and whether the company has concurrent trial/regulatory milestones not mentioned here.
Background
The article is an SEC Form 4 insider transaction disclosure for Pharvaris N.V. (PHVS).
Ticker impact
Pharvaris director Monges Viviane sold 9,667 PHVS shares in an open-market transaction disclosed via SEC Form 4.
Likely limited/short-lived impact; watch for follow-on insider activity or concurrent news.
This is a routine Form 4 insider transaction with no stated 10b5-1 plan and no accompanying company-specific operational update.
Market effects
Minimal; single-company insider sale without clinical/regulatory updates does not reset sector expectations.
None indicated; filing is company-specific.
None indicated; no cross-border deal/regulatory event mentioned.
Counterpoint
Director sales can be planned for liquidity/tax and may not reflect negative fundamentals, especially absent a clear narrative.
Key entities
- issuerPharvaris N.V.
Subject of the Form 4 insider sale: director Monges Viviane sold 9,667 shares at ~$30.2941/share.
- insiderMonges Viviane
Director who executed an open-market sale; holdings reported as 5,500 shares after the transaction.
